No cases of interstitial lung disease were reported, even in patients previously treated with trastuzumab deruxtecan, highlighting a significant safety advantage. Zongertinib demonstrated ...

Beyond efficacy, no drug-related deaths, instances of interstitial lung disease or cardiotoxicity were reported in Lung-1, making for a risk/benefit profile that Boehringer believes is ...

ARP Atlases. 2007;1:17-47. The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate ...

Introduction Interstitial lung disease (ILD) patients may develop a progressive phenotype usually characterised by ...

Weatherby’s newest bolt gun, the Model 307 Alpine CT is very reflective of the current trends. But this rifle also highlights another—newer—trend, which is lighter, long-range precision ...

On safety, there was a case of interstitial lung disease (ILD), a side effect that has been seen with other ADCs using Daiichi Sankyo's deruxtecan payload, like AstraZeneca's Enhertu (trastuzumab ...

advanced PD-L1-positive non-small cell lung cancer (NSCLC). "We evaluate our clinical programmes to focus our resources on the most promising clinically differentiated candidates while ...